[1] Jemal A,Bray F,Center MM,et al. Global cancer statistics [J]. CA Cancer J Clin,2011, 61(2):69-90. [2] Jadoul P,Dolmans MM,Donnez J. Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?[J]. Hum Reprod Update,2010,16(6):617-630. [3] Rowhani-Rahbar A, Mao C, Hughes JP, et al. Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine[J]. Vaccine,2009,27(41):5612-5619. [4] Dobson SR, McNeil S, Dionne M, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial[J]. JAMA,2013,309(17):1793-1802. [5] 董志伟,彭玉.中国癌症筛查及早诊早治技术方案[M]. 北京:人民卫生出版社,2009:104-121. [6] Wang Y, Wang G, Wei LH, et al. Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement[J]. Chin J Cancer,2011,30(9):645-654. [7] Burger RA, Brady MF, Rhee J,et al. Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase Ⅲ trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer[J]. Gynecol Oncol,2013,131(1):21-26. |